M

Mission Bio

124 employees

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

Basic info

Industry

biotechnology research

Sectors

Droplet Microfluidics
Biotechnology
Health Care
Single-cell analysis
Genomics
Precision Genomics
Genetics
DNA Analysis
Bioinformatics
Bioinformatics Support
Precision Medicine

Date founded

2014

Funding rounds raised

Total raised

$70M

from 28 investors over 28 rounds

M

Mission Bio raised $70M on August 13, 2020

Investors: Seabed VC, Cota Capital, Novo Holdings, Mayfield Fund and Soleus Capital Management, L.P.

M

Mission Bio raised undisclosed on March 31, 2020

Investors: Mighty Capital

M

Mission Bio raised undisclosed on March 13, 2020

Investors: Alumni Ventures Group

M

Mission Bio raised $30M on December 13, 2018

Investors: Mayfield Fund, Labcorp, Sand Hill Angels and Cota Capital

M

Mission Bio raised undisclosed on June 29, 2018

Investors: U.S. Department of Health and Human Services (HHS), MBC Biolabs, -, National Institutes of Health, QB3, Mighty Capital, Seabed VC, Sand Hill Angels and Mayfield Fund

M

Mission Bio raised $10M on October 17, 2017

Investors: Life Science Angels, Keiretsu Forum / Capital, Sand Hill Angels, Mayfield Fund, Cota Capital and -

M

Mission Bio raised undisclosed on February 16, 2017

Investors: Keiretsu Capital

M

Mission Bio raised undisclosed on January 1, 2015

Investors: Sand Hill Angels

FAQ